𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PARANOID PSYCHOSIS AFTER DDAVP THERAPY FOR ALZHEIMER'S DEMENTIA

✍ Scribed by Collins, GregoryB.; Marzewski, DavidJ.; Rollins, MichaelB.

Book ID
122894685
Publisher
The Lancet
Year
1981
Tongue
English
Weight
163 KB
Volume
318
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Economic evaluation of cholinesterase in
Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies
✍ Anders Gustavsson; Rohan Van Der Putt; Linus JΓΆnsson; Rupert McShane πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 2 views

## Abstract ## Objective To assess the cost effectiveness of cholinesterase inhibitor (ChEI) treatment in patients with Alzheimer's disease (AD) and Dementia with Lewy bodies (DLB). ## Method We used 4‐month open label follow‐up data from routine memory clinic patients. There were 852 patients w

Risperidone for psychosis of Alzheimer's
Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial
✍ Henry Brodaty; David Ames; John Snowdon; Michael Woodward; Jeff Kirwan; Roger Cl πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 2 views

## Objective: To evaluate the efficacy and safety of low-dose risperidone in treating psychosis of alzheimer's disease (ad) and mixed dementia (md) in a subset of nursing-home residents who had dementia and aggression and who were participating in a randomized placebo-controlled trial of risperidon